Literature DB >> 9861594

Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey.

B Foxman1, J V Marsh, B Gillespie, J D Sobel.   

Abstract

The prevalence of vaginal symptoms and response to those symptoms in a nonclinic setting has not been previously described. Two thousand women living throughout the United States identified by random digit dialing completed a computer-assisted telephone interview about history of vaginal symptoms and use of healthcare services in response to these symptoms. The analysis was limited to 1698 white (WA) and 144 African American (AA) women (n = 1842). An episode of vaginal symptoms of any severity during 1995 was reported by 7.5% of WA women and 18.1% of AA women. Fifty-five percent of WA women and 83% of AA women with symptoms consulted a healthcare professional about their most recent episode. The racial difference in prevalence and consultation was not explained by marital status, education, employment, or lifetime number of sex partners. Most women purchased an over-the-counter antifungal preparation to treat their symptoms, whether or not a physician was consulted. The racial differences in prevalence and use of health services in response to vaginal symptoms observed here should be confirmed, and the potential causes should be explored.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861594     DOI: 10.1089/jwh.1998.7.1167

Source DB:  PubMed          Journal:  J Womens Health        ISSN: 1059-7115            Impact factor:   2.681


  17 in total

1.  FLOW (finding lasting options for women): multicentre randomized controlled trial comparing tampons with menstrual cups.

Authors:  Courtney Howard; Caren Lee Rose; Konia Trouton; Holly Stamm; Danielle Marentette; Nicole Kirkpatrick; Sanja Karalic; Renee Fernandez; Julie Paget
Journal:  Can Fam Physician       Date:  2011-06       Impact factor: 3.275

2.  Pathogenesis of Recurrent Vulvovaginal Candidiasis.

Authors:  Jack D. Sobel
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.725

3.  Updated estimated incidence and prevalence of serious fungal infections in Trinidad and Tobago.

Authors:  Robert Jeffrey Edwards; Gregory Boyce; Ana Alastruey-Izquierdo; David W Denning
Journal:  IJID Reg       Date:  2021-09-27

4.  Glycerol monolaurate inhibits Candida and Gardnerella vaginalis in vitro and in vivo but not Lactobacillus.

Authors:  Kristi L Strandberg; Marnie L Peterson; Ying-Chi Lin; Melinda C Pack; David J Chase; Patrick M Schlievert
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

Review 5.  Management of patients with recurrent vulvovaginal candidiasis.

Authors:  Jack D Sobel
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  In vitro anti-Candida activity of lidocaine and nitroglycerin: alone and combined.

Authors:  Ana Palmeira-de-Oliveira; Ana Rita Ramos; Carlos Gaspar; Rita Palmeira-de-Oliveira; Paula Gouveia; José Martinez-de-Oliveira
Journal:  Infect Dis Obstet Gynecol       Date:  2012-05-20

7.  Validation of a patient-administered questionnaire to measure the activity impairment experienced by women with uncomplicated urinary tract infection: the Activity Impairment Assessment (AIA).

Authors:  Diane J Wild; Darren J Clayson; Karen Keating; Kathleen Gondek
Journal:  Health Qual Life Outcomes       Date:  2005-07-15       Impact factor: 3.186

Review 8.  Interactions of Candida albicans with host epithelial surfaces.

Authors:  David W Williams; Rachael P C Jordan; Xiao-Qing Wei; Carlos T Alves; Matt P Wise; Melanie J Wilson; Michael A O Lewis
Journal:  J Oral Microbiol       Date:  2013-10-21       Impact factor: 5.474

Review 9.  Candida albicans pathogenicity mechanisms.

Authors:  François L Mayer; Duncan Wilson; Bernhard Hube
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

10.  Feminine hygiene practices among female patients and nurses in Lebanon.

Authors:  Elie Attieh; Samer Maalouf; Dina Roumieh; Pamela Abdayem; Georges AbiTayeh; Assaad Kesrouani
Journal:  Reprod Health       Date:  2016-05-23       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.